Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?

被引：55

作者：

Tefferi, Ayalew ^{[1
]}

Gangat, Naseema ^{[1
]}

Wolanskyj, Alexandra P. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

关键词：

D O I：

10.1182/blood-2006-05-025544

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2493 / 2494

页数：2

共 7 条

[1] Barbui T, 2004, HAEMATOLOGICA, V89, P215
[2] HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS
CORTELAZZO, S
FINAZZI, G
RUGGERI, M
VESTRI, O
GALLI, M
RODEGHIERO, F
BARBUI, T
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) : 1132 - 1136
[3] FENAUX P, 1990, CANCER, V66, P549, DOI 10.1002/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO
[4] 2-6
[5] Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia
Harrison, CN
Campbell, PJ
Buck, G
Wheatley, K
East, CL
Bareford, D
Wilkins, BS
van der Walt, JD
Reilly, JT
Grigg, AP
Revell, P
Woodcock, BE
Green, AR
Pearson, TC
Conneally, E
Crawley, C
Cross, NCP
Hall, G
Hunt, B
Lucas, G
Ludlam, C
McMullin, MF
Oscier, D
Radia, D
Reilly, JT
Robinson, G
Culligan, DJ
Tighe, J
Watson, HG
Warren, AJ
Awaad, MO
Obeid, D
Cuthbert, RJG
Kyle, A
Chan-Lam, D
Paul, B
Cuthbert, RJG
McMullin, MF
Morris, TCM
Johnson, RJ
Fegan, C
Milligan, DW
Galloway, MJ
Williamson, PJ
Newton, LJ
Williams, AT
Abboudi, Z
Ryan, K
Lush, R
Blundell, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01) : 33 - 45
[6] Vardiman JW, 2001, WHO CLASSIFICATION T, P17
[7] Essential thrombocythemia beyond the first decade: Life expectancy, long-term complication rates, and prognostic factors
Wolanskyj, AP
Schwager, SM
McClure, RF
Larson, DR
Tefferi, A
[J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (02) : 159 - 166